of 13
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.

Global Molecular Diagnostics Market to be US$ 20.5 Billion by 2024

Category:

Healthcare

Publish on:

Views: 22 | Pages: 13

Extension: PDF | Download: 0

Share
Description
1. Renub Research www.renub.com Global Molecular Diagnostics Market Category: Diagnostics Market Report 2. Renub Research www.renub.com Global Molecular Diagnostics…
Transcript
  • 1. Renub Research www.renub.com Global Molecular Diagnostics Market Category: Diagnostics Market Report
  • 2. Renub Research www.renub.com Global Molecular Diagnostics Market Analyst View: Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. Get Free Customization in this Report Research Report Title: Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others) Access Full Research: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and- future-forecast-414-p.php
  • 3. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. As per Renub Research analysis Global molecular diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years. It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socioeconomic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While, the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics plays a significant role in the diagnosis of infectious diseases as they provide effective results in no time.
  • 4. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php Renub Research report titled “Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription- Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market. By Application – Infectious Disease Testing holds the Maximum Market Share The report studies the market of the following Diagnostics segments: Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others.
  • 5. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024.
  • 6. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. By Technology – PCR Segment is leading the market and will continue so during the Forecast period On the basis of technology, the molecular diagnostics market has been broadly segmented into PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others. By End User – Hospitals & Academic Laboratory holds the Largest Market The report studies the market of the following End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. By Regions – United States and Europe dominates the Molecular Diagnostics Market United States and Europe together controls the Molecular Diagnostics Market. In addition; the report also provides the complete geographical analysis India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World Molecular Diagnostics Market. Companies Analysis Roche, Abbott, Myriad Genetics, Qiagen and BioMérieux are some of the top companies operating in the Molecular Diagnostics; which has been studied thoroughly in the report.
  • 7. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. This market research report provides a complete analysis of the Molecular Diagnostics Market, Growth Drivers, Challenges, and their projections for the upcoming years. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and- future-forecast-414-p.php By Application • Infectious Diseases • Blood Screening • Oncology • Genetic Testing • HLA (Tissue Typing) • Microbiology • Cardiovascular Diseases • Neurological Diseases • Pharmacogenomics • Others By Technology • PCR • Transcription-Mediated Amplification • Hybridiazation • DNA Sequencing & NGS • Microarray • Others
  • 8. Renub Research www.renub.com Global Molecular Diagnostics Market to become US$ 20.5 Billion opportunities by 2024. By End User • Hospitals & Academic Laboratories • Clinics & Commercial Laboratories • Others By Regions • United States • Europe (Expect Russia) • India • China • Japan • Brazil • South Korea • Mexico • Russia • Rest of World
  • 9. Renub Research www.renub.com Table of Contents for Global Molecular Diagnostics Market Key Topics Covered 1. Executive Summary 2. Global Molecular Diagnostic Market 3. Market Share – Global Molecular Diagnostics 3.1 By Application 3.2 By Technology 3.3 By Countries 3.4 By Companies 4. Application – Molecular Diagnostics Market 4.1 Infectious Diseases 4.2 Blood Screening 4.3 Oncology / Cancer 4.4 Genetic Testing 4.5 HLA (Tissue Typing) 4.6 Microbiology 4.7 Cardiovascular Diseases 4.8 Neurological Diseases 4.9 Pharmacogenomics 4.10 Others
  • 10. Renub Research www.renub.com Table of Contents for Global Molecular Diagnostics Market 5. Technology – Molecular Diagnostics Market 5.1 PCR 5.2 Transcription-Mediated Amplification 5.3 Hybridiazation 5.4 DNA Sequencing & NGS 5.5 Microarray 5.6 Others 6. Region - Molecular Diagnostics Market 6.1 United States 6.2 Europe 6.3 India 6.4 China 6.5 Japan 6.6 Brazil 6.7 South Korea 6.8 Mexico 6.9 Russia 6.10 Rest of World (ROW) 7. End Users - Molecular Diagnostics Market 7.1 Hospitals & Academic Laboratories 7.2 Clinics and Commercial Laboratories 7.3 Others
  • 11. Renub Research www.renub.com Table of Contents for Global Molecular Diagnostics Market 8. Roche Diagnostics – Company Analysis 8.1 Merger & Acquisitions 8.2 Sales Analysis 9. Abbott Laboratories – Company Analysis 9.1 Merger & Acquisitions 9.2 Sales Analysis 10. Myriad Genetics – Company Analysis 10.1 Merger & Acquisitions 10.2 Sales Analysis 11. Qiagen – Company Analysis 11.1 Merger & Acquisitions 11.2 Sales Analysis 12. BioMérieux’s Inc – Company Analysis 12.1 Merger & Acquisitions 12.2 Sales Analysis
  • 12. Renub Research www.renub.com Table of Contents for Global Molecular Diagnostics Market 13. Market Drivers 13.1 Various Developments in the Molecular Diagnostics Landscape 13.2 Integral to Traditional Labs 13.3 Improved Assay / Test Efficiencies 13.4 Targeting Antibiotic Resistance 13.5 Next Generation Ultrasensitive Molecular Diagnostics 13.6 Increasing Investment in Genomics & Proteomics Research 13.7 Technological Advances in Molecular Diagnostics 13.8 Increasing Acceptance of the Personalized Medicine 13.9 Growing Molecular Diagnostics for Food Safety 14. Challenges 14.1 Dearth of Trained Professionals 14.2 Regulatory Issues 14.3 Various Factors Slowing Growth of Molecular Diagnostics 14.4 Reimbursement Capabilities 14.5 Quality Checkpoints, Awareness & Acceptance
  • 13. Renub Research www.renub.com Get Free Customization in this Report Diagnostics Market Reports: https://www.renub.com/diagnostics-14-c.php Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel: +1-678-302-0700 Email: info@renub.com www.renub.com Renub Research - Asia Ankit Mishra C – 86, Sector – 10 Noida 201301, India Tel: +91-120-421-9822 Email: info@renub.com www.renub.com
  • We Need Your Support
    Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

    Thanks to everyone for your continued support.

    No, Thanks